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Abstract 
 
Abnormal repetitive behaviors (ARBs) are a prominent symptom of numerous human brain disorders 
and are commonly seen in rodent models. As rodent studies of ARBs continue to dominate the field, 
mounting evidence suggests that zebrafish (Danio rerio) also display ARB-like phenotypes and may 
therefore be a novel model organism for ARB research. In addition to practical research advantages, 
zebrafish share high genetic and physiological homology to humans and rodents, including multiple 
ARB-related genes and stereotypic behaviors relevant to ARB. Here, we discuss a wide spectrum of 
stereotypic repetitive behaviors in zebrafish, data on their genetic and pharmacological modulation, 
and the overall translational relevance of fish ARBs to modeling human brain disorders. Overall, the 
zebrafish is rapidly emerging as a new promising model to study ARBs and their underlying 
mechanisms.          
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1. Introduction 
 Abnormal repetitive behaviors (ARBs) commonly occur in neuropsychiatric diseases, 
including obsessive-compulsive disorder (OCD), autism spectrum disorder (ASD), trichotillomania, 
Parkinson’s disease, as well as Tourette’s, Rett, Fragile X and Prader-Willi syndromes [1-3]. Typical 
ARBs include abnormal motor behavior, disrupted social interactions, aberrant goal-oriented behavior 
and self-injurious cycled actions [4]. In humans, the most frequent ARBs include skin-picking, head-
hitting, repetitive manipulation of objects (spinning, twirling), repetitive use of language, body 
rocking, hand flapping, finger flicking and tics [5, 6]. Highly relevant clinically [1, 7, 8], some ARBs 
(e.g., skin-picking, hair-pulling) may also cause physical harm [9, 10]. Together, this emphasizes the 
growing clinical importance of ARBs and the need for their broad-scale translational research. 
 Animal experimental models are a powerful tool in neuroscience and biological psychiatry, 
markedly improving our understanding of CNS function and dysfunction [11-13]. Behaviorally, ARBs 
can be divided into two groups – motor stereotypies and impulsive/compulsive behaviors [14-16]. The 
former include the repetition of purposeless movements and/or body postures, whereas the latter 
involve cognitive inflexibility and aberrant goal-oriented behaviors [17-20]. Clinical motor 
stereotypies include repetitive stereotypical motor movements (SMMs), critical for neuropsychiatric 
diagnostics. Common SMMs include body rocking, hand flapping and finger moving, often seen in 
patients with ASD, Fragile X syndrome, Rett syndrome, Parkinson’s disease (e.g., periodic fast/slow 
finger movements), and Huntington’s disease [21-27]. Other common ARBs are tics, often occurring 
in Tourette’s syndrome [28] as unconscious, abrupt, periodical and arhythmical movements or 
vocalizations [1, 29]. OCD symptoms include complex ARBs stemming from persistent recurrent 
compulsive ideas [30], combining composite behavioral acts (compulsions or rituals) with repeated 
behaviors (e.g., washing and cleaning) that, unlike tics, are conscious [1]. 
 Given a wide spectrum of ARBs and multiple distinct CNS disorders with ARB-like 
phenotypes, the complex neurobiology of repetitive behaviors is poorly understood [31, 32]. However, 
the basic neuroanatomy and neuronal circuitry are beginning to unravel for some ARBs in both clinical 
and animal studies. For example, magnetic resonance imaging (MRI) in both humans and rodents has 
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revealed core brain structures involved in the regulation of motor behavioral patterns, including 
sensory motor and anterior cingulate cortex, cerebellum, thalamus and the basal ganglia [33-39]. 
Paralleling clinical findings, several rodent models with overt spontaneous stereotypies (e.g. deer mice, 
BTBR T+tf/J, C57BL/10, C57BL/6, C58 mice) are widely used to study ARBs, in which affected 
animals display repetitive jumping and self-grooming [40-43]. Neurochemical and clinical volumetric 
studies of the basal ganglia pathways implicate all major neurotransmitters in ARBs [44]. For example, 
OCD responds to selective serotonin reuptake inhibitors (SSRIs) [45], and disturbances in the 
serotonin transporter (SERT) are common in humans with OCD [46] and in animal models of this 
disorder [47, 48]. Likewise, gamma-aminobutyric acid (GABA), glutamate, noradrenaline, histamine, 
acetylcholine, cannabinoids, endogenous opioids and hypothalamic-pituitary-adrenal (HPA) axis 
hormones serve as reliable biomarkers of repetitive behavior [44, 49].  
 Various CNS disorders comorbid with ARBs have strong genetic determinants, including 
neuroligin (NLGN),  GABA A-receptor β3 gene (GABRB3), methyl-CpG-binding protein 2 (MeCP2), 
the fragile X mental retardation (FMR1), contactin-associated protein-like 2 (Cntnap2), SHANK 
family, tuberous sclerosis complex 1 (TSC1), neurexin 1a (NRXN1) [50-52] and dopamine D3 receptor 
genes (DRD3) [53, 54]. Neuroligin genes (e.g., NLGN3) modulate dopaminergic signaling in ventral 
striatum [55], and mouse knockouts in NLGN3 display robust motor stereotypies [55]. Other genes 
essential for GABA- and glutamatergic signaling are implicated in ARB pathogenesis [56]. For 
example, MeCP2 (encoding transcriptional regulator MeCP2) and GABRB3 (encoding the β3 subunit 
of the GABAA receptor) are associated with Rett and Prader-Willi syndromes [57-59]. Likewise, 
GABARB3 knockout mice display repetitive circling and tail chasing [60, 61], whereas MeCP2-
deficient mice exhibit impaired GABA signaling with forelimb stereotypies [62]. Genes related to 
aberrant glutamatergic signaling include SHANK2 and other SHANK genes (responsible for stability 
of excitatory synapses [56]), and their disturbances may trigger repetitive jumping [63]. Mice lacking 
genes affecting glutamate NMDA receptors (e.g., ninjurin 1/ning1) and grin1 (glutamate ionotropic 
receptor NMDA type subunit 1) exhibit compulsive grooming resembling clinical OCD [64, 65].  
In summary, the genetic contribution to ARBs, established in preclinical and clinical genetics 
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studies (Table 1), confirm shared core mechanisms of ARB pathogenesis in humans and rodent models 
[66-68], calling for further translational research in this field. However, as humans and rodents share 
80-85% genetic homology, it is logical to ask whether shared ARB pathways are generally 
evolutionarily conserved across vertebrate taxa? For example, while mutant mice with DAT genetic 
ablation show multiple repetitive behaviors [69-72], zebrafish (Danio rerio) with DAT genetic 
knockout can become a powerful model of DAT-mediated behavioral deficits. Generated recently, 
these mutant zebrafish display thigmotaxis (swimming closely to the walls of the tank, Fig. 3) [73] 
which may represent an ARB-like phenotype. Given a 70-75% of genetic homology between humans 
and zebrafish [74], their generally similar CNS [75] and core neurotransmitters, neurohormones [76], 
and their molecular targets [77-79], can experimental modeling of ARBs be extended to include fish 
models? In other words, can fish have ARBs? And, if they do, - how can ARBs of animals, separated 
from humans by thousands of years of evolution, inform us about core mechanisms underlying ARB 
pathogenesis? 
 2. ARB lessons from zebrafish 
While the vast majority of pre-clinical ARB data have been obtained from rodent models [43, 
80-86] (Table 1), the growing understanding of evolutionarily conserved core mechanisms of CNS 
disorders [12] necessitates novel models, new model organisms, and translational cross-species 
comparisons in the field of ARB research [87]. A small teleost fish, the zebrafish is rapidly gaining 
popularity in preclinical studies modeling human brain diseases [88] as a low-cost and research-
efficient vertebrate organism [89] with fast development highly suitable for CNS research [90]. 
Notably, transparency of embryos allows the observation of zebrafish CNS in vivo, further enhanced 
by zebrafish brain using imaging tools [91]. Finally, remarkable genetic and physiological similarity 
to humans, simply quantifiable overt behavioral responses, shared neural circuits and sensitivity to 
psychotrophic drugs make zebrafish an appropriate model species in preclinical studies of human CNS 
disorders [91, 92].  
Similar to rodent models, many basic behavioral patterns of zebrafish can be assessed in 
observation tanks similar to rodent open field tests, such as novel tank tests [93, 94]. Albeit not showing 
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some common rodent open field stereotypies (e.g., self-grooming), fish have their own set of 
stereotypic movements that can be recognized, quantified and modulated experimentally [95]. For 
example, zebrafish stereotypies are often observed in response to pharmacological intervention, and 
include repeated back-and-forth swimming at a particular part of the tank (e.g., at the bottom, middle, 
or top of the tank) [96], but may also include more specific behavioral pattern, such as stereotypic 
circling - repetitive round trajectory swimming, that is common for ketamine and other glutamatergic 
antagonists [97, 98] (Table 2). Furthermore, adult zebrafish may display repetitive thigmotaxis often 
seen following psychostimulant (e.g., nicotine) administration, and manifested as stereotypic 
swimming along the walls of the tank near the surface (similar to stereotypic locomotion of other 
model species in the open field test [99]).  
However, it is premature to interpret such behavioral patterns without thorough mechanistic 
analyses and complementing behavioral observations with pharmacological and genetic challenges to 
target ARBs. For example, recent studies of the neurophysiological underpinnings of repetitive turning 
and other ARB-like behavior have focused on zebrafish larvae, revealing an important role of hindbrain 
in such fish phenotypes [100-102]. Likewise, assessing thigmotaxis and its relevance to ARBs in 
rodents [103] and zebrafish [99], such responses can be also related to alternation in luminance, and 
represent a tendency to swim outward (rather than the preference for the edges) [104].     
 2.1. Autism-related models 
Like in rodents, disruption of some ASD-related genes provokes ARB-like phenotypes in 
zebrafish. For example, SHANK3 knockout zebrafish display aberrant circling, thigmotaxis, corner-to-
corner swimming and ‘looped’ figure-8 swimming [105]. With high homology of SHANK3 between 
rodents and zebrafish (Table 2), such fish ARBs resemble stereotypies in mouse mutants of this gene 
[106-108]. SYNGAP1 encoding synaptic Ras GTPase activating protein 1 is a critical regulator of 
glutamatergic NMDA-receptors [109] implicated in ASD [109, 110]. Zebrafish SYNGAP1 knockouts 
display remarkable stereotypic movements, including prolonged undulating swimming with frequent 
C-bends, accompanied by aberrant mid- and hindbrain development [111]. Contactin-associated 
protein-like 2 gene (CNTNAP2) triggers epilepsy and ASD [112, 113] by disrupting inhibitory GABA-
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ergic neurotransmission [114, 115]. In line with ASD-like ARBs in CNTNAP2 knockout mice [116, 
117], zebrafish CNTNAP2 mutants also display higher responsivity to GABA-A receptor inhibitors, 
causing circling and burst-like movements [118]. Thus, the disruption of key ASD-related genes leads 
to the development of stereotypic movements in zebrafish.  
The fragile X syndrome, clinically distinct from ASD, has an overlapping ARB phenotype with 
typical stereotypic movements, hand flapping and biting [119-121] triggered by aberrant activity of an 
X chromosome gene FMR1 (fragile X mental retardation 1) crucial for CNS development, 
neurotransmission and synaptic stability [122, 123]. FMR1 knockout rodents display aberrant jumping, 
circling, digging and increased self-grooming [124, 125]. Although zebrafish FMR1 knockouts and 
knockdowns have craniofacial alterations, aberrant neurotransmission (e.g., cholinergic in motor 
neurons, glutamatergic in the CNS) and behavioral changes (e.g., hyperactivity [126-129]), their ARBs 
have not yet been noted [127], necessitating further studies using this model organism.  
 Rett syndrome is another debilitating disorder genetically related to the X chromosome, mainly 
affecting females and manifesting in stereotyped hand wringing, rubbing or clapping movements 
[130]. The main candidate gene for Rett syndrome is MeCP2 [131], and MeCP2 knockout mice display 
similar neurological deficits [132], including ARB-like hindlimb clasping and altered dopamine and 
glutamate signaling [133, 134]. Zebrafish MeCP2 knockouts display abnormal thigmotaxis, likely 
associated with neurodevelopmental abnormalities in the hindbrain [135], and the MeCP2 knockdown 
impairs neurodevelopment and neurodifferentiation in larval fish [136].  
2.2. Modeling obsessive-compulsive disorder in zebrafish 
There are strong parallels between OCD and other ARB-related conditions, and animal models 
of OCD proposed based on their phenotypic stereotypy profiles, include genetic models (e.g., hyper-
dopaminergic mutant deer mice [137, 138] and Sapap, Slitrk5 and HoxB8 knockout mice [139]), drug-
induced and some other models [43, 140, 141]. Zebrafish models of OCD are gaining value in 
neuropsychiatric research [142-145]. Currently, there are many behavioral tasks that can be used to 
assess OCD phenotypes in zebrafish and that may be differently classified when using larvae or adult 
animals. Larvae OCD-like phenotypes are commonly analyzed by video-tracking software and 
8 
 
comprise subtle stereotypic movements such as dashing, freezing and repetitive rotational turns [142]. 
A recent method to analyze swimming behavior in zebrafish larvae [146] improves the analysis of their 
behavioral profiles and can be used as an important tool for OCD drug discovery assays. In addition 
to larvae, OCD phenotypes can be measured in adult zebrafish by assessing their stereotypic 
movements and compulsive choice [93, 142] (see further).  
The early studies using adult zebrafish focused on drug-induced locomotor effects to better 
understand OCD-related stereotypic behavior in zebrafish novel tank test, a paradigm similar to the 
open field in rodents [93]. For example, this has revealed stereotypic behavior in adult zebrafish 
expressed as repetitive rotations or “circling behavior”, such as those induced by NMDA receptor 
antagonists (e.g., ketamine) [147]. This approach has clear translational concordance with OCD and 
its treatment [148, 149], as ketamine and other NMDA antagonists often evoke stereotypic circling in 
humans and rodents. Zebrafish exposed to ibogaine (a hallucinogen with some NMDA antagonist 
activity that induces stereotypic behavior in rodents [150]) display circling behavior and repetitive 
corner-to-corner swimming [151]. Repetitive, unvarying perseverative behavior without goal or 
function has been described in zebrafish following cocaine withdrawal [130]. The predictive validity 
of stereotypic behavior in translational models is based on response to SSRIs which ameliorate OCD 
symptoms [152]. Notably, 5-HT1B receptor antagonists can induce repetitive behavior in zebrafish 
[153] that can be reversed by known OCD treatments (e.g., fluoxetine [154]) with striatal activation 
modulated only by specific OCD treatments [153]. 
Compulsive choice is another important OCD-related behavior frequently studied in rodent 
models [69] by subjecting the rodent to the spontaneous alternation test [155] and using the “signal 
attenuation” model [82]. In zebrafish, a compulsive choice can be studied in a T- or Y-maze assessing 
habit formation. Briefly, during acquisition of a learning task, normal animals will use both olfactory 
and visual stimuli to learn the location of food. Once the task is well learned, the animal will develop 
a ‘habit’ in which the amount of cognitive processing of the array of stimuli in the environment will 
be lower, as evidenced by lower sensitivity to devaluation, and by reduced sensitivity to contingency 
degradation [156-158]. Importantly, alterations in habit-forming have been observed in OCD patients 
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[159], suggesting that such behavior is an important marker of this disorder [160, 161]. In line with 
this, zebrafish exposed to alcohol during early brain development form habits early in the learning 
process in an adaptation of the T-maze “place-response” test Parker, Evans [162]. Such tests can be 
further validated by drugs traditionally used to treat OCD-related symptoms (e.g., fluoxetine), thus 
providing face and predictive validity for zebrafish models of  stereotypic behavior and habit formation 
in OCD-like phenotypes [93, 142]. 
2.3. Cognitive inflexibility 
Cognitive flexibility is the ability to adjust and adapt cognitive processing strategies in response 
to new, unexpected challenges [163]. Conceptually, it is the opposite end of the spectrum to ARBs, 
which are rigid and fixed. Therefore, understanding the biology of cognitive and behavioral flexibility 
may offer much to the study of ARBs, and vice versa [85]. Thus, to more closely translate the animal 
model to human OCD [1], assessment of cognitive flexibility-rigidity needs to be related to observed 
compulsive behaviors [164]. One method of measuring behavioral flexibility is attention set shifting 
tasks, which requires learning the response to a simple ‘rule’ applied to a complex stimulus, to identify 
relevant or non-relevant cues, and then modifying the response when the rule is changed, i.e. 
responding to the previously irrelevant (instead of the relevant, reinforced) cue [165]. Reductions in 
cognitive flexibility are seen in patients suffering from various neuropsychiatric disorders, including 
OCD and ASD [166], making it an important endophenotype to observe and model [167, 168].  
Many neuropsychiatric diseases affecting the frontal cortex have deficits in cognitive flexibility 
signified by increased perseveration for the previous rule and increased errors shifting from one rule 
to the next [166]. Notably, the severity of the condition (i.e., in OCD patients) correlates with the 
deficit in reversal learning [166, 169]. Another paradigm, similar to that in primates and rodents [165, 
170], has been adapted for zebrafish. For example, zebrafish are able to discriminate two colored cues 
(using a food reinforcer), demonstrating the capacity for to make ‘choices’ about differently valued 
stimuli. Zebrafish are also capable of cognitive flexibility, in terms of their responses to reversal 
learning and intra-dimensional set-shifting [171]. During a typical reversal learning protocol, an 
animal initially is trained (Phase 1) on a discrete-trial protocol to discriminate between two 
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differentially reinforced stimuli (e.g., colors: RED = S+ [reinforced], GREEN = S- [non-reinforced]). 
Once it has reached a criterion of response allocation to the reinforced alternative (e.g., 6-correct 
responses in a row), the reinforced and non-reinforced alternatives are reversed (GREEN = S+, RED 
= S-; Phase 2). During Phase 2, the animal initially shows low correct responses, but gradually learns 
that S-  from phase 1 is now S+, and reaches criterion on Phase 2. In Phase 3, the colors are switched 
to a new pair (intra-dimensional set shift; e.g., BLUE = S+, YELLOW = S-). In the final phase (Phase 
4), the two new colors are reversed. If the animal is showing cognitive flexibility, the hypothesis in a 
reversal learning experiment such as this is that the animal will reach criteria more quickly as the 
phases continue, on account of their switching the ‘rule’ by which they are performing responses on 
the task in an adaptive manner. Zebrafish require progressively fewer trials to reach learning criterion 
as a function of phase, confirming that this species can be cognitively flexible [172]. Thus, zebrafish 
performance on tasks of cognitive flexibility renders them ideal for the study of ARB, as cognitive 
inflexibility is a hallmark of ARBs. Together with the ease of genetic and pharmacological 
manipulations, zebrafish may further our knowledge on the cognitive-psychobiological aspects of 
cognitive flexibility in ARB-related disorders.  
 Another area of executive function that can be measured is working (e.g., spatial) memory 
[173]. The Y-maze (Fig. 4), a three-armed maze to record spontaneous alternation [174], has been 
adapted for zebrafish [175] as a useful tool for testing fish. Mazes can be set up in the presence or 
absence of any motivational or emotional factors, therefore permitting measures of motivation and 
learning or pure novelty seeking with minimal confound [175]. Automation of this task has enabled 
minimum user interaction and ease of recording several different variables from a single trial. A recent 
study employing the Y-maze used an analysis of overlapping tetragrams (i.e., in 100 trials, 16 
overlapping tetragrams ranging from RRRR to LLLL [176]) to determine how zebrafish explore the 
maze in a 1-h trial, revealing aberrant alternations in fish developmentally exposed to ethanol. Thus, 
the Y-maze has the potential of a flexible and relatively high-throughput method for assessing 
executive functions associated with learning and working memory. With some further investigation, 
the Y-maze can be an excellent tool for evaluating neuropsychiatric disorders with both extreme and 
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more subtle ARBs, thus broadening our ability to model cognitive dysfunction in zebrafish. Indeed, 
age-related changes in patterns of alternation and repetition have been found in zebrafish (Fig. 4). 
Given overt stereotypies as part of the typical behavioral repertoire of infant humans (reducing with 
age in normative development) [177, 178], repetitive movements in the aquatic Y-maze may mimic 
ARBs observed in human development.  
3. Existing challenges, model limitations, and future directions 
Clearly, numerous challenges exist in the development of zebrafish models of ARBs. For 
example, how to properly translate animal repetitive behavors into human ARBs? Indeed, several of 
clinical ARB symptoms are difficult, if not impossible, to observe in zebrafish. Therefore, the question 
is whether the behaviors selected in order to determine ARB are sufficient to call these animal 
behaviors ARBs. Another problem concerns the overall reliability of behavioral tests recognized 
recently and requiring an urgent sonution [179, 180]. One way to solve it is to ensure that standard 
protocols are published and utilised by groups using the same behavioral endpoints. Another strategy 
is to ensure automation is used as widely as possible. As stated earlier, this will be expedited by the 
recent advent and availability of commercially available automated testing hardware. Third, 
laboratories should adhere to standardized reporting protocols, such as the ARRIVE guidelines [181], 
to ensure that intra-laboratory procedures are transparent and fully repeatable, aiming to maximize 
interlaboratory reliability. Fourth, laboratories should be encouraged to share data and protocols in a 
timely manner, even from negative experiments, via preprint online servers, to enable fast and accurate 
reproduction of protocols across the community, and facilitate interlaboratory collaboration, if 
necessary. 
In addition to challenges mentioned above, one of the most useful aspects of the zebrafish 
model is the ability to carry out high-throughput testing in a vertebrate system. To a certain extent, this 
is possible in adult fish using protocols outlined above. However, there are some drawbacks to using 
adult zebrafish which are similar to those associated with mammalian model systems, includung 
practical problems with cost of housing, space constraints, long-term isolation of a sentient social 
species, and individual behavioral variance. Therefore, the more active use of larvae should be 
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considered, especially given the development of larval assays of complex behaviors (e.g., impulsivity) 
[182] which may be usful in the early characterization of ARBs, with strong links between behavioral 
compulsions and impulse control [183, 184]. Finally, in order for zebrafish to prove useful to study 
mechanisms of ARBs, several fundamental questions need to be addressed. Indeed, the underlying 
mechanics of normal action selection in zebrafish remain unclear. For example, what neural circuits 
underlie choice behavior, behavioral flexibility, and balance between various basal ganglia pathways? 
Once we have the answers to this question, zebrafish will be extremely useful in understanding the 
neural circuits underlying ARB (also see Table 2 for strategic directions in the study of ARBs using 
this organism).  
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Figure 1. Selected repetitive behavior in zebrafish. Panel A shows how drugs can affect zebrafish 
behavior in novel tank test. For example, acute ketamine exposure may induce characteristic repetitive 
behavioral patterns in zebrafish swimming, paralleling ketamine-evoked circling in rodents and clini-
cal stereotypies (see [147] for details). Panel B illustrates thigmotaxis in adult zebrafish, as they typi-
cally prefer to swim close to the walls of the tank [185]. Albeit potentially reflecting increased anxiety-
like behavior in some contexts (e.g., anxiogenic center avoidance), this response may also represent a 
pathological repetitive behavior (e.g., evoked by psychostimulants, such as nicotine) relevant to stere-
otypic peripheral hyperlocomotion, commonly seen in rodents (e.g., following psychostimulant drugs) 
(adapted from [186]).  
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Figure 2. Selected examples of genetic models of aberrant repetitive behaviors in zebrafish. 
SHANK3 (left panel) is an autism-related gene that encodes postsynaptic density protein (PSD, bind-
ing to glutamatergic NMDA receptors) whose ablation in mice impairs synaptic transmission. Knock-
down of SHANK in zebrafish up-regulates NMDA receptor and evokes ARB-like repetitive circling, 
corner-to-corner and figure-8 swimming (top view), according to [105]. A synaptic ras GTPase-acti-
vating protein SYNGAP1 (right panel) is another key protein involved in synaptic transmission, whose 
hypofunction in mice induces precocious maturation of synapses and increases synaptic transmission. 
NMDA receptor interact with postsynaptic density-95 (PSD-95) protein, which binds to SYNGAP. 
SYNGAP1 knockdown zebrafish demonstrate overt stereotypic movements, including prolonged un-
dulating swimming with frequent C-turns (top view), according to [187] 
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Figure 3. A brief summary of ARB-like behavioral phenotype of the dopamine transporter (DAT) 
knockout zebrafish, including swimming predominantly at the bottom of the tank with characteristic 
thigmotaxis (moving along the walls of the tank), according to [73]   
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Figure 4. The use of Y-maze to assess behaviorally flexible patterns of swimming (alternation 
and repetition) in zebrafish. This test also reveals certain developmental changes in zebrafish 
swimming, ranging from pure alternation (LRLR, RLRL) to pure repetition of previous response 
(RRRR, LLLL, Parker laboratory, unpublished data). Overall, young fish show high levels of pure 
repetition and pure alternation, whereas older zebrafish show lower levels of repetition relative to 
alternation. 
 
 
  
Pure repetition 
(RRRR, LLLL) 
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Table 1. Selected animal models that parallel clinical symptoms of ARBs 
 
Rodents Zebrafish 
ARB Ref-
er-
ences  
ARB Refer-
ences 
Pharmacological    
Rat ASD model (prenatal valproate) evokes re-
petitive locomotion (back-and-forth moving) 
[188] Acute ketamine* induces increased circling be-
havior, Fig. 1 
[147] 
Amphetamine exposure in C58/J mice evokes 
repeated cage-lid back-flipping 
[65] Acute dizocilpine (MK-801)* increased cir-
cling behavior 
[98] 
Rat 6-OHDA** brain lesions (a Parkinson’s 
model) evoke compulsive lever-pressing under 
chronic pramipexole*** 
[189] Phencyclidine (PCP)* increased circling be-
havior 
[190] 
Rat prenatal exposure to lipopolysaccharide 
(LPS) increases repetitive self-grooming 
[191] The mixture of crude oil with lead increases 
cycle swimming in 15 larvae    
[192] 
Deer mice exhibit increased repetitive jumping 
following apomorphine***  
[193] Stereotypic corner-to-corner swimming at the 
bottom of the tank under ibogaine 
[151] 
Genetic    
Shank1 knockout mice display increased self-
grooming 
[194] Adult mecp2 mutants exhibit overt thigmotaxis [135] 
Histidine decarboxylase knockout mice display 
increased self-grooming  
[195] Shank3b knockouts display figure “8” swim-
ming, circling, cornering and walling (Fig. 2) 
[105] 
Mice with deleted Netrin-G ligand 2 (NGL-2) 
gene display increased self-grooming 
[196] Syngap1a knockdowns escape responses with 
prolonged repetitive C-bends    
[111] 
Hoxb8 KO mice (an OCD model) display patho-
logical self-grooming 
[139] CNTNAP2 mutant larvae display burst-like and 
circling movements  
[118] 
MeCP2 deficient mice display stereotyped fore-
paw movements and compulsive self-grooming 
[62] Adult DAT knockouts exhibit increased thig-
motaxis  
[73] 
 
*An antagonist of glutamate NMDA receptors 
**6-hydroxydopamine, a neurotoxic antidopaminergic agent 
***An agonist of several dopamine receptors 
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Table 2. Comparative genetic homology between human, rodent and zebrafish ARB-related 
genes, based on the Basic Local Alignment Search Tool (BLAST, www.blast.ncbi.nlm.nih.gov) 
database  
 
Gene Comparison: query coverage/homology  
Human vs 
Mouse 
Human vs 
Zebrafish 
Mouse vs 
Zebrafish 
SLC6A3   48%/87% 42%/79% 48%/78% 
FMR1  96%/89% 30%/75% 30%/75% 
MeCP2   82%/82%  5%/70%  5%/68%  
CNTNAP2   64%/81%  38%/68%  54%/68% 
SHANK1  73%/85%  28%/70%  35%/72% 
SHANK2 (zebrafish – shank2b gene)  48%/86%  35%/70%  27%/76% 
SHANK3 *  99%/85%  34-41%/71%   35-41%/73% 
TSC1 (zebrafish – tsc1a, tsc1b)  64%/81%  7-17%/69-72%  8-23%/69-73% 
GABRB3**   97%/81%  20%/79%  21%/80% 
DRD3  86%/88%  44%/74%  51%/75% 
5-HT2C  96%/83% 15%/70% 16%/69% 
SYNGAP1***  67%/ 92%  43%/73%**** No similarity 
HOXb8 (zebrafish: hoxb8a, hoxb8b)  99%/90%  37%/71-75%  25%/70-75% 
SLC1A1  82%/81%  37%/70%  38%/72% 
 
* Zebrafish shank3a – PREDICTED transcript variant X18, shank3b – PREDICTED transcript variant X4 
** Human/mouse – transcript variant 1, zebrafish – PREDICTED transcript variant X1 
*** Human – transcript variant 1, zebrafish: syngap1a – PREDICTED transcript variant X2, syngap1b 
**** No similarity with syngap1b 
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Table 3. Selected open questions in the field of zebrafish modeling of ARBs 
 
Questions 
Conceptual 
• What is entire spectrum of neurobehavioral ARB-like phenotypes in zebrafish? 
• Which brain structures are implicated in zebrafish ARBs? 
• Are there links between zebrafish ARB and social behavioral deficit? 
• How is normal motor sequence selection modified (varied) based on prior motor sequence performance in zebrafish? 
• How do alterations in mechanisms of motor sequence selection lead to repeated invariant behavioral sequences (ARBs)? 
• Are ARBs a neurological phenomenon, or the result of alterations in interaction with the environment? 
• Can ARBs spontaneously emerge in zebrafish (i.e., as a result of chronic isolation/under-stimulation)? 
• Can a zebrafish be ‘bored’? 
• Can ARBs in zebrafish be qualitatively differentiated from ‘normal’ behavior, and modeled, mathematically? 
• Do larval zebrafish display overt ARBs? Are they similar to those seen in adult fish? 
• Is there a pathological link between ARBs, self-aggression, and aggression? Can this be modeled in zebrafish? 
• Do ARBs display aging-related trajectories in zebrafish? 
• How does stress affect zebrafish ARBs? 
• Do zebrafish use ARBs in social or sexual contexts? 
• Do zebrafish ARBs display circadian rhythms? 
Translational 
•  What are the mechanisms of normal motor sequence selection and invigoration in zebrafish? 
• What is the homology in mechanics and/or circuitry of motor sequence selection between zebrafish and mammals? 
• If zebrafish ARB can be quantified into subunits or predictable patterns? Can they help test drugs or mimic human ARB? 
• Is there a substantial homology between human and zebrafish ARB-related neurocircuitry? 
• Do stress-evoked alterations in zebrafish ARBs resemble those evoked in human ARBs? 
• Do zebrafish ARBs respond to various drugs similarly to human ARBs?  
• How does impulsivity contribute to zebrafish ARB expression? 
• How does zebrafish individuality (‘personality’) affect ARB-like phenotypic variance in zebrafish populations? 
• Are there robust sex differences in some zebrafish ARBs similar to those in humans with certain CNS disorders? 
• Are there common/shared epigenetic mechanisms of ARB regulation in mammals and zebrafish? 
• Do aging-related ARBs in zebrafish resemble those observed in aging humans?   
Methodological 
• Can zebrafish ARBs be fractionated into quantifiable sub-units, in terms of predictable patterns of expression? 
• What is the potential for the development of a zebrafish ARB ethogram? 
• Can a zebrafish be trained to produce ARB? 
• Can a zebrafish that shows ARB be trained to stop producing these patterns? 
• What are neuroendocrine biomarkers of zebrafish ARBs? 
• Are there well-established strain differences in zebrafish ARBs? 
• Do zebrafish ARBs differ between the laboratories and/or between different vendors? 
• Do wild-caught zebrafish display ARBs? Do ARBs increase during domestication? 
• To what extent ARBs may concomitantly affect other neurobehavioral responses 
• Are there reliable tools for automated quantification of ARBs in zebrafish? 
• Are tools available for high-throughput multi-animal detection of ARBs in zebrafish groups? 
Others 
• Do zebrafish ARBs represent an animal welfare problem? 
• Can improved welfare (e.g., by using environmental enrichment) reduce zebrafish ARBs? 
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